Pearse B M
Laboratory of Molecular Biology, Medical Research Council Centre, Cambridge, UK.
EMBO J. 1988 Nov;7(11):3331-6. doi: 10.1002/j.1460-2075.1988.tb03204.x.
An affinity matrix of LDL receptor cytoplasmic tails binds the HA-II 100/50/16 kd complexes found in plasma membrane coated pits. Other receptors (or their cytoplasmic domains), which are localized in coated pits during endocytosis, inhibit this binding. This includes an 8 residue peptide containing tyrosine, corresponding to the cytoplasmic portion of a mutant influenza haemagglutinin. In contrast, the equivalent peptide lacking tyrosine (like the tail of the native haemagglutinin, a protein excluded from coated pits) does not compete. These results imply that the HA-II complex has a recognition site for a common signal, probably involving a tyrosine residue, carried by the LDL receptor and competing receptors also found in plasma membrane coated pits. The HA-II complex therefore fulfils the role of an 'adaptor', the name proposed for the structural units which mediate the binding of clathrin to receptors in coated vesicles. Another related complex, the HA-I adaptor, which is restricted to Golgi coated pits, probably does not recognize the 'tyrosine signal' on the LDL receptor tail. The HA-I adaptor is likely to contain a recognition site for a different signal carried by receptors, e.g. the mannose-6-phosphate receptor, which are found in Golgi coated pits.
低密度脂蛋白受体胞质尾的亲和基质与质膜包被小窝中发现的HA-II 100/50/16 kd复合物结合。在内吞作用期间定位于包被小窝的其他受体(或其胞质结构域)会抑制这种结合。这包括一个含酪氨酸的8个残基的肽,对应于突变型流感血凝素的胞质部分。相反,缺乏酪氨酸的等效肽(如天然血凝素的尾部,一种不包含在包被小窝中的蛋白质)不参与竞争。这些结果表明,HA-II复合物具有一个针对共同信号的识别位点,该信号可能涉及酪氨酸残基,由低密度脂蛋白受体携带,并且在质膜包被小窝中也发现有竞争受体携带该信号。因此,HA-II复合物起到了“衔接蛋白”的作用,“衔接蛋白”是为介导网格蛋白与包被小泡中受体结合的结构单元所提出的名称。另一种相关复合物,即HA-I衔接蛋白,其局限于高尔基体包被小窝,可能不识别低密度脂蛋白受体尾部的“酪氨酸信号”。HA-I衔接蛋白可能含有一个针对受体携带不同信号的识别位点,例如在高尔基体包被小窝中发现的甘露糖-6-磷酸受体。